PolyMedix, Inc. (OTC:PYMX) has announced that it will host a webcast on Tuesday, December 15, 2009 at 10:00 am ET. The webcast will be held to discuss Heparin, Bleeding Complications, and PolyMedix’s PMX-60056 Heparin Reversing Agent. The webcast will be accessible at http://events.vcall.com/VCall/ParticipantLogin.aspx?BID=1&Room=95235.
MicroCap Insider is a web-based financial portal that publishes a free penny stock newsletter providing stock alerts on companies positioned to deliver high-yield gains to investors. Sign Up for our Free Stock Newsletter
Publicly traded, PolyMedix is a biotechnology company with a focus on developing novel drugs and biomaterials to treat infectious diseases and acute cardiovascular disorders. The company’s goal is to develop rapidly acting antibiotics for serious systemic and local infections. The company intends to continue developing polymeric formulations as antimicrobial biomaterials for use in paints, plastics, and textiles.
Investors interested in receiving small cap stock alerts through the penny stock newsletter published by MicroCap Insider can sign up for free by visiting our website
About Us
MicroCap Insider is a leading penny stock web site with extensive experience in the OTC market, providing top stock picks, investing tips and exclusive research on small cap stocks on the verge of producing large financial gains.
Please click here to read the full disclaimer